Delivery Order SPE2DB24D9222-SPE2DB25FAZFB

Award Date 3/6/25
Potential Completion Date 3/27/25
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order worth $8,220.68 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price award for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product, with a period of performance through March 17, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,220.68 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,441.36 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables...
This federal contract award, valued at $7,824.35, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order under the DLA's SPE2DB Indefinite Delivery Contract (IDC), which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. Under this contract, DMS Pharmaceutical Group will provide the DLA with STELARA 90 MG/ML...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,974.08 firm fixed-price delivery order is for the pharmaceutical product Stelara 130 mg/26 ml vial, with a period of performance through December 30, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,441.36 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $24,662.04 firm fixed-price contract is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,324.08 firm fixed-price contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA), under its Medical Supply Chain division, to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $6,217.60 delivery order contract is for the supply of STELARA 130 MG/26 ML VIAL 26ML, a specialty pharmaceutical product. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, under the SPE2DB program. This...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product, at a ceiling value of $8,931.48. The contract has an ultimate completion date of October 25, 2024 and is a firm fixed-price delivery order. DMS Pharmaceutical Group Inc. holds a...
  • SPE2DB24D9222
    Indefinite Delivery Contract
  • SPE2DB24D9222-SPE2DB25FAZFB
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $24,662.04 firm fixed-price delivery order contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product.

DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This specific award is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal contracts across various medical product categories. The contract has an ultimate completion date of March 27, 2025.

Generated 6/5/25, 10:17 AM